HK1068334A1 - Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments - Google Patents

Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments

Info

Publication number
HK1068334A1
HK1068334A1 HK05100306A HK05100306A HK1068334A1 HK 1068334 A1 HK1068334 A1 HK 1068334A1 HK 05100306 A HK05100306 A HK 05100306A HK 05100306 A HK05100306 A HK 05100306A HK 1068334 A1 HK1068334 A1 HK 1068334A1
Authority
HK
Hong Kong
Prior art keywords
linear
branched
alkyl
aryl
alkenyl
Prior art date
Application number
HK05100306A
Other languages
English (en)
Inventor
Giorgio Tarzia
Giovanni Piersanti
Patrizia Minetti
Maria Assunta Dicesare
Grazia Gallo
Fabrizio Giorgi
Luca Giorgi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1068334A1 publication Critical patent/HK1068334A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
HK05100306A 2001-07-31 2005-01-13 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments HK1068334A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000465A ITRM20010465A1 (it) 2001-07-31 2001-07-31 Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam
PCT/IT2002/000489 WO2003011864A1 (en) 2001-07-31 2002-07-25 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS

Publications (1)

Publication Number Publication Date
HK1068334A1 true HK1068334A1 (en) 2005-04-29

Family

ID=11455703

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100306A HK1068334A1 (en) 2001-07-31 2005-01-13 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments

Country Status (19)

Country Link
US (2) US7230102B2 (xx)
EP (1) EP1412354B1 (xx)
JP (1) JP4366186B2 (xx)
KR (1) KR100884818B1 (xx)
CN (1) CN1271070C (xx)
AT (1) ATE325796T1 (xx)
AU (1) AU2002326146B2 (xx)
BR (1) BR0211550A (xx)
CA (1) CA2451279C (xx)
DE (1) DE60211343T2 (xx)
DK (1) DK1412354T3 (xx)
ES (1) ES2263810T3 (xx)
HK (1) HK1068334A1 (xx)
HU (1) HU228985B1 (xx)
IT (1) ITRM20010465A1 (xx)
MX (1) MXPA04000886A (xx)
PL (1) PL217269B1 (xx)
PT (1) PT1412354E (xx)
WO (1) WO2003011864A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451244C (en) * 2001-06-29 2012-01-17 Cv Therapeutics, Inc. Purine derivatives as a2b adenosine receptor antagonists
ITRM20010465A1 (it) * 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam
ES2279903T3 (es) * 2001-12-18 2007-09-01 Cv Therapeutics, Inc. Antagonistas del receptor a2a de adenosina.
RU2397171C2 (ru) 2004-03-26 2010-08-20 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. 9-замещенное производное 8-оксоаденина и лекарственное средство
CA2646891A1 (en) * 2006-03-23 2007-09-27 Novartis Ag Immunopotentiating compounds
EP2041135A4 (en) 2006-07-05 2010-12-01 Astrazeneca Ab As TLR7 MODULATORS, 8-OXOADENINE DERIVATIVES WORK
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
SI2132209T1 (sl) 2007-03-19 2014-05-30 Astrazeneca Ab Spojine 9-substituiranega-8-okso-adenina, kot modulatorji Toll-like receptorja (TLR7)
WO2008114006A1 (en) 2007-03-19 2008-09-25 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
JPWO2008114819A1 (ja) 2007-03-20 2010-07-08 大日本住友製薬株式会社 新規アデニン化合物
MX2009009936A (es) * 2007-03-20 2010-02-11 Curis Inc Amino piridina fusionada como inhibidores de hsp90.
PE20081887A1 (es) * 2007-03-20 2009-01-16 Dainippon Sumitomo Pharma Co Nuevo compuesto de adenina
ES2393037T3 (es) * 2007-05-08 2012-12-18 Astrazeneca Ab Imidazoquinolinas con propiedades inmunomoduladoras
UY31531A1 (es) 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
US20110054168A1 (en) * 2008-01-17 2011-03-03 Ayumu Kurimoto Method for preparing adenine compound
JP5577099B2 (ja) 2008-01-17 2014-08-20 大日本住友製薬株式会社 アデニン化合物の製造方法
TWI473614B (zh) 2008-05-29 2015-02-21 Kyowa Hakko Kirin Co Ltd Anti-analgesic inhibitors
WO2010003048A1 (en) 2008-07-03 2010-01-07 Sirtris Pharmaceuticals, Inc. Benzimidazoles and related analogs as sirtuin modulators
CA2731573C (en) * 2008-07-23 2018-09-18 Kyowa Hakko Kirin Co., Ltd. Selective adenosine a2a receptor antagonists useful in the treatment and prevention of migraine
US9133197B2 (en) * 2009-03-20 2015-09-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments
KR101830623B1 (ko) 2009-11-13 2018-02-21 아카데미아 시니카 신경퇴화 질병의 예방 및 치료를 위해 아데노신 ａ２ａ 수용기 및 아데노신 수송체를 표적화하는 이중-작용 화합물
JP2013512859A (ja) * 2009-12-03 2013-04-18 大日本住友製薬株式会社 トール様受容体（ｔｌｒ）を介して作用するイミダゾキノリン
EP2657236A4 (en) * 2010-11-24 2014-02-26 Yamasa Corp NEW 2-ALKYNYL-N9-PROPARGYLADENINE AND ITS MEDICAL USE
JP5978225B2 (ja) 2010-12-16 2016-08-24 大日本住友製薬株式会社 治療に有用なイミダゾ［４，５−ｃ］キノリン−１−イル誘導体
US8895570B2 (en) 2010-12-17 2014-11-25 Astrazeneca Ab Purine derivatives
JP2016512219A (ja) 2013-03-15 2016-04-25 シンジェンタ パーティシペーションズ アーゲー 殺菌活性のあるイミダゾピリジン誘導体
CN105622495A (zh) * 2016-03-23 2016-06-01 叶芳 4-氯-3-硝基吡啶及其制备方法
GB2555264A (en) 2016-04-15 2018-04-25 Univ Oxford Innovation Ltd Adenosine receptor modulators for the treatment of circadian rhythm disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0457773A4 (en) 1989-01-31 1993-03-10 Whitby Research Incorporated N?6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5670501A (en) * 1994-09-01 1997-09-23 Discovery Therapeutics, Inc. N-substituted 9-alkyladenines
CA2315736A1 (en) * 1998-01-05 1999-07-15 Eisai Co., Ltd. Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus
GB9915437D0 (en) 1999-07-01 1999-09-01 Cerebrus Ltd Chemical compounds III
CA2451244C (en) * 2001-06-29 2012-01-17 Cv Therapeutics, Inc. Purine derivatives as a2b adenosine receptor antagonists
ITRM20010465A1 (it) * 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam

Also Published As

Publication number Publication date
ES2263810T3 (es) 2006-12-16
HUP0401987A3 (en) 2012-12-28
ITRM20010465A1 (it) 2003-01-31
US7230102B2 (en) 2007-06-12
HUP0401987A2 (hu) 2005-01-28
HU228985B1 (en) 2013-07-29
AU2002326146B2 (en) 2008-05-01
PT1412354E (pt) 2006-09-29
US20070249638A1 (en) 2007-10-25
DE60211343T2 (de) 2007-05-10
EP1412354A1 (en) 2004-04-28
KR20040023641A (ko) 2004-03-18
ATE325796T1 (de) 2006-06-15
ITRM20010465A0 (it) 2001-07-31
JP4366186B2 (ja) 2009-11-18
WO2003011864A1 (en) 2003-02-13
JP2005500355A (ja) 2005-01-06
DK1412354T3 (da) 2006-09-18
CN1271070C (zh) 2006-08-23
KR100884818B1 (ko) 2009-02-20
PL368409A1 (en) 2005-03-21
CN1525974A (zh) 2004-09-01
BR0211550A (pt) 2004-07-13
MXPA04000886A (es) 2004-06-03
CA2451279C (en) 2011-05-10
CA2451279A1 (en) 2003-02-13
US20040204428A1 (en) 2004-10-14
PL217269B1 (pl) 2014-06-30
US7528252B2 (en) 2009-05-05
EP1412354B1 (en) 2006-05-10
DE60211343D1 (de) 2006-06-14

Similar Documents

Publication Publication Date Title
HK1068334A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
TW200716528A (en) Cyclopropanecarboxamide derivatives
MY126862A (en) Purine derivatives inhibitors of tyrosine protein kinase syk
NL350075I2 (xx)
HUP0204226A2 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0401047A2 (hu) Triazolo[4,5-d]pirimidin-származékok, alkalmazásuk purinergikus receptor-antagonistákként és a vegyületet tartalmazó gyógyszerkészítmények
HUP0102471A2 (hu) 4-Benzil-piperidin alkilszulfoxid heterociklusok és használatuk altípus-szelektív NMDA antagonistaként és ezeket tartalmazó gyógyszerkészítmények
MY139357A (en) Novel benzoimidazole derivatives useful as antiproliferative agents
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
GEP20084357B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
YU55603A (sh) Derivati purina kao antagonisti purinergiskog receptora
MXPA04000577A (es) Derivados de dolastatina 10.
TW200517109A (en) Substituted pyridinones
HUP0300618A2 (hu) Adamantánszármazékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
RS20050732A (xx) Supstituisani pirimidinoni
MY137156A (en) Dual nk1/nk3 derivatives
MXPA04001240A (es) Analogos antitumorales.
HUP0102300A2 (hu) Diazepinszármazékok alkalmazása szomatosztatin-receptor által befolyásolt betegségek kezelésére szánt gyógyszerek előállítására, valamint új vegyületek
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
IL179171A0 (en) Alkyl substituted indoloquinoxalines
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
MXPA04000407A (es) Derivados de fenilacetamido-tiazol, procedimiento para su preparacion y uso como agentes antitumorales.
EP1022276A4 (en) EPOXYSuccinic acid amide derivatives
NZ515407A (en) 4-Phenyl-pyrimidine derivatives
HUP0303004A2 (hu) Új [(alkil-fenil)-imino]-imidazolidin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk vizeletinkontinencia kezelésére szolgáló gyógyszerkészítmények előállítására